Sangamo Therapeutics Inc.
Clinical‑stage genomic medicine company converting science into therapies for hemophilia, Fabry disease, kidney transplant rejection, and neurodegenerative disorders, supported by alliances with Biogen, Pfizer, Sanofi, and Novartis.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 183
- HQ: Richmond
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.